Since FDA Approval, Several Studies Highlight Benefits of IV Ferric Carboxymaltose
Trials such as HEART-FID and AFFIRM-AHF have demonstrated positive treatment results for injectable ferric carboxymaltose in patients with heart failure and iron deficiency.
Source: ajmc.com